Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

212 trials

NCT06735911
Recruiting
Assessment of the Effect of a Dermatology-Oriented Spa Therapy on the Quality of Life of Patients With Psoriasis
Not applicable · France · 2 sites
Registry update: 13 May 2025
NCT06865105
Recruiting
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
Phase 2 · Canada, Czechia, France, Hungary, Poland, United States · 41 sites
Registry update: 9 Nov 2026
NCT06842316
Recruiting
Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
Not applicable · France · 1 site
Registry update: 30 Dec 2025
NCT07150000
Recruiting
Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
Not applicable · Germany · 1 site
Registry update: 2 Sept 2025
NCT07017699
Recruiting
A Study to Assess Deucravacitinib Safety in Pregnancy
Not applicable · United States · 1 site
Registry update: 1 Oct 2026
NCT06842199
Recruiting
Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis
Phase 3 · China · 46 sites
Registry update: 9 Feb 2026
NCT06937060
Recruiting
Effect of Semaglutide in Patients With Psoriasis and Obesity
Phase 3 · Hong Kong · 1 site
Registry update: 13 May 2025
NCT06857942
Recruiting
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Phase 4 · United States · 38 sites
Registry update: 4 Nov 2026
NCT06997055
Recruiting
ROLL'YN-UST: an Observational Study in Patients Treated by Steqeyma®, an Ustekinumab Biosimilar
Not applicable · France · 1 site
Registry update: 30 May 2025
NCT06870500
Recruiting
Card14gene (rs34367357 ) Polymorphism in Egyptian Psoriatic and Psoriatic Arthritis Patient
Not applicable · Egypt · 1 site
Registry update: 11 Mar 2025
NCT06671483
Recruiting
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Phase 3 · Belgium, Bulgaria, Chile, Czechia, Germany, Estonia, Spain, Croatia, Hungary, Israel, Italy, South Korea, Latvia, Mexico, New Zealand, Poland, Puerto Rico, Portugal, Taiwan, United States · 187 sites
Registry update: 14 Oct 2026
Conflicting statuses (updated in the registry within the last month)
NCT06893913
Recruiting
Effect of Addition of Pyramidal Exercise to Intermittent Fasting on Dryness of Eye in Pre-diabetic Psoriasis Patients
Not applicable · Egypt · 1 site
Registry update: 25 Mar 2025
NCT06696417
Recruiting
Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis
Not applicable · China · 1 site
Registry update: 14 May 2025
NCT07615257
Recruiting
Managing Psychological Distress Through Mindfulness-based CBT to Evaluate Its Effectiveness on Self-compassion Among Psoriasis Patients:The Mediating Role of Mental Health Locus of Control
Not applicable · Pakistan · 1 site
Registry update: 29 May 2026
NCT06801821
Recruiting
Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
Not applicable · Italy · 1 site
Registry update: 26 Aug 2025
NCT06764693
Recruiting
An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
Not applicable · Argentina, Austria, Belgium, Bulgaria, Czechia, Germany, Spain, France, Greece, Ireland, Israel, Italy, Poland, Saudi Arabia, Taiwan · 132 sites
Registry update: 17 Feb 2026
NCT06701513
Recruiting
A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)
Not applicable · Switzerland, France · 34 sites
Registry update: 18 May 2026
NCT06382051
Recruiting
Modifying PEST for Psoriatic Arthritis Screening
Not applicable · Canada · 21 sites
Registry update: 28 Sept 2026
NCT05725876
Recruiting
Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis.
Phase 1 · Netherlands · 1 site
Registry update: 15 Jan 2025
NCT06574178
Recruiting
Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet
Not applicable · United States · 1 site
Registry update: 16 Jun 2026

Ordered by registry start date. Freshness and sponsorship never change the order.